Giverny Capital Inc. cut its position in AMETEK, Inc. (NYSE:AME) by 0.4% in the 1st quarter, HoldingsChannel.com reports. The firm owned 762,627 shares of the technology company’s stock after selling 2,999 shares during the quarter. AMETEK comprises 7.3% of Giverny Capital Inc.’s holdings, making the stock its 3rd largest position. Giverny Capital Inc.’s holdings in AMETEK were worth $63,275,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently made changes to their positions in AME. Vanguard Group Inc increased its holdings in shares of AMETEK by 0.6% in the third quarter. Vanguard Group Inc now owns 23,495,237 shares of the technology company’s stock worth $1,858,943,000 after purchasing an additional 137,102 shares during the last quarter. IFP Advisors Inc increased its stake in AMETEK by 76.4% during the fourth quarter. IFP Advisors Inc now owns 441 shares of the technology company’s stock worth $29,000 after acquiring an additional 191 shares during the last quarter. Oppenheimer Asset Management Inc. bought a new stake in AMETEK during the fourth quarter worth approximately $150,000. BB&T Securities LLC increased its stake in AMETEK by 4.3% during the fourth quarter. BB&T Securities LLC now owns 8,285 shares of the technology company’s stock worth $560,000 after acquiring an additional 338 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund increased its stake in AMETEK by 6,587.0% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 1,702,384 shares of the technology company’s stock worth $25,000 after acquiring an additional 1,676,926 shares during the last quarter. Institutional investors and hedge funds own 85.92% of the company’s stock.

Shares of NYSE:AME traded down $0.69 during trading hours on Friday, hitting $84.99. 737,766 shares of the company’s stock traded hands, compared to its average volume of 1,061,681. AMETEK, Inc. has a 1 year low of $63.14 and a 1 year high of $88.76. The firm has a market capitalization of $19.36 billion, a PE ratio of 25.83, a price-to-earnings-growth ratio of 2.17 and a beta of 1.21. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.91 and a quick ratio of 1.27.

AMETEK (NYSE:AME) last announced its earnings results on Wednesday, May 1st. The technology company reported $1.00 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.97 by $0.03. AMETEK had a return on equity of 18.56% and a net margin of 16.14%. The business had revenue of $1.29 billion during the quarter, compared to analyst estimates of $1.28 billion. During the same quarter in the previous year, the business earned $0.79 earnings per share. The company’s revenue for the quarter was up 9.8% compared to the same quarter last year. Equities research analysts expect that AMETEK, Inc. will post 4.08 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Friday, June 14th will be given a dividend of $0.14 per share. The ex-dividend date is Thursday, June 13th. This represents a $0.56 annualized dividend and a dividend yield of 0.66%. AMETEK’s dividend payout ratio (DPR) is presently 17.02%.

Several equities research analysts have weighed in on AME shares. DA Davidson boosted their price objective on AMETEK to $92.00 and gave the stock a “buy” rating in a research note on Friday, March 15th. ValuEngine raised AMETEK from a “hold” rating to a “buy” rating in a research note on Wednesday, May 1st. KeyCorp boosted their price objective on AMETEK from $86.00 to $94.00 and gave the stock an “overweight” rating in a research note on Thursday, May 2nd. BMO Capital Markets boosted their price objective on AMETEK from $99.00 to $101.00 and gave the stock an “outperform” rating in a research note on Thursday, May 2nd. Finally, Vertical Research reissued a “buy” rating on shares of AMETEK in a research note on Friday, May 3rd. Fifteen analysts have rated the stock with a buy rating, The stock has a consensus rating of “Buy” and a consensus price target of $91.50.

In other AMETEK news, Director Steven W. Kohlhagen sold 3,494 shares of the business’s stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $81.78, for a total transaction of $285,739.32. Following the completion of the transaction, the director now owns 55,003 shares in the company, valued at $4,498,145.34. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider David A. Zapico sold 58,760 shares of the business’s stock in a transaction that occurred on Tuesday, June 11th. The shares were sold at an average price of $86.35, for a total value of $5,073,926.00. Following the transaction, the insider now owns 258,226 shares of the company’s stock, valued at approximately $22,297,815.10. The disclosure for this sale can be found here. Insiders have sold 73,614 shares of company stock valued at $6,314,246 in the last 90 days. Company insiders own 0.80% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was first posted by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of international copyright laws. The original version of this piece of content can be accessed at https://www.watchlistnews.com/ametek-inc-nyseame-shares-sold-by-giverny-capital-inc/3043451.html.

AMETEK Profile

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. The company's Electronic Instruments segment offers advanced instruments for the process, aerospace, power, and industrial markets; process control instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.

Further Reading: What is a growth and income fund?

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME).

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.